Symptom tracking and doctor-led teleconsults for Indian women in perimenopause
TL;DR Changecourse is a 6-month perimenopause programme with a daily symptom diary, video consults with gynaecologists who treat menopause, and lifestyle coaching built around the woman's own pattern. Women in their 40s pay for it themselves, and employers can buy it as a benefit. It sells informed care, not hormone gadgets.
India had about 96 million women aged 45 and over at the 2011 census, and studies put the average age of menopause anywhere from 41.9 to 49.4, earlier than in the West[1]. Among women aged 45–49, about half had already reached menopause[1]. In a community survey of 970 women around Tirupati, 88% reported symptoms[2].
So how much structured help do they get? Very little. Hot flushes, poor sleep, mood swings and irregular bleeding get passed around between a general physician, a gynaecologist and the family chat group, and many women don't link the symptoms to perimenopause at all. Few doctors have the time to track them month to month.
The regulatory bit first - Changecourse runs telemedicine consults in which registered doctors diagnose and treat, plus a symptom diary that is wellness-only. The app records and charts. It does not diagnose, score risk or suggest drugs. Prescribing follows the Telemedicine Practice Guidelines 2020[8].
The seed idea was continuous hormone monitoring, and I dropped it for two reasons. No continuous sensor for oestrogen or FSH is on the market, and the closest product reads one saliva strip at a time[4]. NICE guidance also says that in healthy women over 45, perimenopause should be diagnosed from symptoms and period changes, because FSH and other hormones swing too much to help[3].
So Changecourse personalises from what actually changes care. A woman logs flushes, sleep, mood and bleeding in under a minute a day. After four weeks her gynaecologist sees a chart instead of a vague memory and talks through options, from lifestyle changes to non-hormonal drugs or hormone therapy where suitable. A coach follows up on sleep, exercise and weight, which the Tirupati study linked most closely to symptoms[2]. Labs get ordered only when the doctor needs them.
The user and the payer are usually the same person - an urban woman aged 40–55 with her own income. Indian programmes already charge for this kind of support, and one Bengaluru menopause startup's programmes start at ₹4,999[5]. My estimate for Changecourse is ₹6,000–9,000 for six months, with consult fees inside the price. The second payer is the employer. Companies with lots of women in senior roles are an easier sell than individual consumers, but I found no published Indian price for menopause benefits.
Telemedicine prescribing has had clear rules since March 2020[8]. That startup's US$1.5 million seed round in 2021 showed investors would back Indian midlife care[6]. In the US, one virtual menopause clinic reports serving more than 500,000 women through virtual menopause care[7], so the format clearly works at scale. Hormone gadgets are arriving too, like at-home saliva hormone tests in 2025–26[4], and that makes an honest, evidence-led alternative easier to explain.
Nobody publishes a figure for what Indian women spend on menopause care. The firm numbers are the 96 million women aged 45-plus at the last census[1] and existing programme prices from ₹4,999[5].
The Bengaluru startup's site claims 60,000-plus users, though it shows two different figures and both are self-reported[5]. Treat demand as proven in pockets and unmeasured nationally.
One Bengaluru startup sells menopause programmes, supplements and home blood panels, with gynaecologists on hand[5]. Another women's health platform, funded in January 2023, covers women's health "from menstruation to menopause" and already sells to employers as well as consumers[9]. A US virtual menopause clinic is the closest model for clinical care, with virtual visits by menopause clinicians billed to insurance[7].
The gap in India is narrower than it looks - a service built only for perimenopause, where every consult runs on months of the woman's own symptom data.
| Difficulty | Moderate (37/100) |
| Starting capital | ₹55 L–1.2 Cr |
| Time to launch | 4–6 months |
The software is simple. The hard part is the clinician panel, because India has few gynaecologists who focus on menopause and they're busy people. You also need women to log symptoms for a month before the first consult pays off, and apps in this space tend to lose users quickly.
There's no licence for the company itself, but the consults and the app both sit under rules you follow from day one.
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
Don't let AI diagnose perimenopause or suggest hormones. The app records and charts, and the doctor decides treatment.
Want to work out the AI layer for Changecourse? Talk to Yash →
Here's what can go south -
I think this is a sensible, capital-light idea for a founder with women's-health or clinic operations experience and access to two or three respected gynaecologists. If you're set on building hormone hardware then it's a poor fit.
First prove that women will keep a diary for four weeks and pay for the consult that follows.
My estimate is ₹55 L–1.2 Cr to launch, covering the app, the gynaecologist panel, coaches and early marketing. The kit has the line-by-line breakdown.
Not for the company, but every consult must follow the Telemedicine Practice Guidelines 2020 and only registered doctors can prescribe. Keep the app to recording and charting.
Yes, and US virtual clinics show virtual menopause care can scale. Telehealth and prescribing rules differ though, so check with your own regulator first.
The free Changecourse validation kit has the line-by-line capital breakdown, the effort scoring, the telemedicine and data-protection checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for women and employers, and 5 assumptions to test. Download the kit →
Thinking about building Changecourse or something close to it? The make-or-break work is a gynaecologist panel that follows one protocol and keeping women engaged past the first month, and I'm happy to think that through with you. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.